Coller Capital Ltd. is a London-based investment firm established in 1990, specializing in private equity's secondary market and direct investments. The firm offers liquidity solutions for investors seeking to exit their private equity investments, which may include limited partner positions or portfolios of direct investments in private companies. Coller Capital focuses on a variety of investment strategies, including late-stage and emerging growth investments, management buyouts, and restructuring. The firm invests globally, with particular emphasis on sectors such as life sciences, telecommunications, real estate, and information technology. Typical investment sizes range from $1 million to over $1 billion, and Coller Capital often seeks to be the lead investor, taking minority stakes in medium-sized companies. The firm aims to exit investments within four to six years, primarily through initial public offerings or trade sales. Additionally, Coller Capital has offices in New York and Hong Kong, expanding its global reach.
Zepz is an online service that facilitates international money transfers, allowing users to send funds to friends and family living abroad through various digital platforms such as computers, smartphones, or tablets. It provides a convenient and cost-effective alternative to traditional money transfer methods, which often involve high fees and in-person agents. Zepz enables recipients to receive money through several options, including bank deposits, cash pickups, mobile money accounts, or mobile airtime top-ups. The service is accessible to senders in 50 countries and supports transfers to over 140 destinations across Europe, Asia, Africa, Australia, and the Americas, effectively catering to a global customer base.
IntelePeer
Venture Round in 2024
IntelePeer is a communications automation platform that utilizes generative AI to enhance customer interactions for businesses. By offering a cloud-based Communications Platform as a Service (CPaaS), the company provides on-demand IP communications and SIP trunking services tailored for enterprises. IntelePeer's platform integrates seamlessly with existing systems, allowing businesses to streamline their communication processes across multiple channels. Its focus on automation not only reduces operational costs but also improves customer experience by delivering efficient and effective communication solutions. The incorporation of AI and analytics further enhances the platform's capabilities, enabling clients to achieve higher levels of customer satisfaction and engagement.
Ssangyong C&E
Private Equity Round in 2022
SsangYong C&E is a private cement manufacturer based in South Korea, known for its significant contributions to the local cement industry through technological innovation and quality enhancement. The company operates manufacturing facilities in Donghae and Yeonwol, producing a range of products including Portland cement, blended cement, specialty cement, and mortar. In addition to cement production, SsangYong C&E is involved in waste recycling and other environmentally related businesses, as well as the sale of petroleum products. The firm is distinguished by having established the first independent technology research center in its sector, underscoring its commitment to advancing industry standards.
Exterro
Private Equity Round in 2022
Exterro, Inc. is a provider of e-discovery and information governance software solutions focused on the legal and IT markets, serving Fortune 500 corporations as well as law firms and government agencies. Founded in 2004 and headquartered in Beaverton, Oregon, the company offers the Fusion Platform, which integrates with existing enterprise technologies to connect stakeholders such as legal, IT, records management, and compliance teams. Exterro’s solutions include E-Discovery Data Mapping for creating data maps of electronically stored information, Legal Hold for compliance with privacy laws, and E-Discovery Data Management for collection and review processes. Additionally, it provides project management tools for legal teams, a case law library for reference, and cloud-based e-discovery software. The company's offerings aim to enhance collaboration, mitigate risks, and streamline legal processes, thereby enabling organizations to better manage governance, risk, and compliance challenges.
Hoxton Farms
Seed Round in 2020
Hoxton Farms, located in London, UK, specializes in producing real animal fat without the use of animals. The company employs a combination of cell biology and mathematical modeling to cultivate purified animal fat in bioreactors. This innovative approach provides a sustainable and cruelty-free ingredient for the meat alternatives industry, as well as applications in other sectors such as bakery, confectionery, and cosmetics. By focusing on cultivated fat, Hoxton Farms aims to meet the growing demand for ethical and environmentally friendly food products.
BOOK A TIGER
Series B in 2017
BOOK A TIGER is an Integrated Facility Management Platform. It provides customers with access to high quality cleaning services as well as additional services through its connected partner network.
uniQure
Private Equity Round in 2013
uniQure is a pioneering gene therapy company recognized for developing the first gene therapy product to receive regulatory approval in the European Union. Its initial product, Glybera, was authorized in October 2012 for treating patients with lipoprotein lipase deficiency, a rare and severe metabolic disorder. uniQure specializes in creating innovative gene therapies that offer long-term and potentially curative benefits for genetic and acquired diseases. The company utilizes a modular technology platform and a proprietary manufacturing process to develop its treatments. Currently, uniQure is expanding its pipeline of adeno-associated virus (AAV)-based gene therapies, focusing on conditions such as hemophilia, Huntington's disease, and cardiovascular diseases through collaborations, including one with Bristol Myers Squibb. While the company initially targets orphan diseases, it also aims to address chronic and degenerative diseases affecting larger populations.
Societe Innovatech du Grand Montreal
Acquisition in 2004
Societe Innovatech du Grand Montreal
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.